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A B S T R A C T
1,2-propanediol (1,2-PDO) is an industrial chemical with a broad range of applications, such as the production
of alkyd and unsaturated polyester resins. It is currently produced as a racemic mixture from nonrenewable
petroleum-based feedstocks. We have reported a novel artificial pathway for the biosynthesis of 1,2-PDO via
lactic acid isomers as the intermediates. The pathway circumvents the cytotoxicity issue caused by
methylglyoxal intermediate in the naturally existing pathway. Successful E. coli bioconversion of lactic acid
to 1,2-PDO was shown in previous report. Here, we demonstrated the engineering of E. coli host strains for the
de novo biosynthesis of 1,2-PDO through this pathway. Under fermenter-controlled conditions, the R-1,2-PDO
was produced at 17.3 g/L with a molar yield of 42.2% from glucose, while the S-isomer was produced at 9.3 g/L
with a molar yield of 23.2%. The optical purities of the two isomers were 97.5% ee (R) and 99.3% ee (S),
respectively. To the best of our knowledge, these are the highest titers of 1,2-PDO biosynthesized by either
natural producer or engineered microbial strains that are published in peer-reviewed journals.
1. Introduction
Microbial strains are rich sources of catalytic activities that enable
both in vitro and in vivo biosyntheses of useful molecules at high titer,
yield, and quite often, with superior stereoselectivity from a variety of
renewable carbon sources, including lignocellulosic materials and CO2
(Sheldon, 2014; Lee et al., 2012; Nielsen and Keasling, 2016). The
biosynthetic power of a single microbe is further expanded when
enzymes with promiscuous substrate specificity are exposed to
molecular species that share the same functional group and similar
carbon skeleton to their native substrates. Synthetic pathways can
therefore be devised by combining enzymatic activities from different
biological sources into a single host strain in order to achieve the
synthesis of target molecules that are not endogenous metabolites or
are not even natural products (Weeks and Chang, 2011; Niu et al.,
2016; Chatsurachai et al., 2012; Campodonico et al., 2014; Niu et al.,
2003; Yim et al., 2011). Moreover, synthetic pathways are also explored
for natural products in order to provide ingenious solutions to
engineering problems that are intrinsic to naturally existing routes
(Atsumi et al., 2008; Bogorad et al., 2013).
1,2-Propanediol (1,2-PDO) is a commodity chemical with an annual
global consumption of over 1.5 million metric tons and annual global
market value of $2.7 billion in 2007 (Shelley, 2007). It is an
intermediate in the production of alkyd resins for paints and high-
performance, unsaturated polyester resins. It is also the preferred
ingredient in coolant and deicing agent over ethylene glycol, due to its
low melting point and low toxicity. Because of its Generally Recognized
As Safe (GRAS) status, 1,2-PDO of pharmaceutical grade is widely used
as co-solvent for low water-soluble compounds in drug and food
formulation (Forkner et al., 2005). Current industrial production of
1,2-PDO racemic mixture is mainly through high pressure, high
temperature, noncatalytic hydrolysis of propylene oxide, which is a
building block derived from non-renewable petroleum resources
(Forkner et al., 2005). Renewable synthesis of 1,2-PDO through
microbial catalysis has been studied for decades (Shelley, 2007). As a
natural product, accumulation of 1,2-PDO was first reported in the
culture of Clostridium thermobutylicum (Lennart, 1954). The biosyn-
thetic pathway (Fig. 1b) was later delineated (Cameron and Cooney,
1986) and engineered into E. coli hosts for 1,2-PDO synthesis from
glucose and glycerol (Altaras and Cameron, 2000; Clomburg and
Gonzalez, 2011). The best titer of 4.9 g/L (0.19 g/g) and 5.6 g/L
(0.21 g/g) was achieved when glucose and glycerol was provided as
the carbon source, respectively (Clomburg and Gonzalez, 2011). None
of the engineered strains was able to outperform the natural producer
C. thermosaccharolyticum, which produced 1,2-PDO at a final titer of
9.0 g/L (0.2 g/g) from glucose (Sanchez-Riera et al., 1987). One major
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obstacle in the engineering of the natural 1,2-PDO pathway lies in the
cytotoxicity inflicted by the obligate biosynthetic intermediate methyl-
glyoxal at submillimolar concentrations (Fig. 1b) (Totemeyer et al.,
1998; Booth et al., 2003). To circumvent this problem, we have
previously designed a synthetic 1,2-PDO pathway in which the
common fermentation product, lactic acid, was chosen as the branch-
ing point of 1,2-PDO synthesis from E. coli fermentative metabolism
(Fig. 1a) (Niu and Guo, 2015). In addition to the elimination of
methylglyoxal as an intermediate, the synthetic pathway can potentially
enable the exclusive accumulation of the R- or the S-1,2-PDO stereo-
isomer from the D- or the L-lactic acid intermediates. In this report, we
present the engineering strategy of E. coli hosts that enabled the de
novo biosynthesis of 1,2-PDO directly from glucose as the carbon
source. We examined culturing conditions and genetic manipulations
to optimize the flux into the 1,2-PDO pathway. Under fed-batch
fermentation conditions, engineered E. coli strains produced
1,2-PDO stereoisomers of high optical purity at final concentrations
of 17.3 g/L (R-) and 9.3 g/L (S-), respectively.
2. Materials and methods
2.1. General methods
All commercial chemicals are of reagent grade or higher. Acetyl-
CoA, sodium D-lactate, sodium L-lactate, NADH, and NADPH were
purchased from Sigma. All solutions were prepared in deionized water
that was further treated by Barnstead Nanopure® ultrapure water
purification system (Thermo Fisher Scientific Inc). Bacterial strains
constructed and used in this study are listed in Table 1. LB medium
(1 L) contained Bacto tryptone (10 g), Bacto yeast extract (5 g), and
NaCl (10 g). M9 salts (1 L) contained Na2HPO4 (6 g), KH2PO4 (3 g),
NH4Cl (1 g), and NaCl (0.5 g). M9 glucose medium contained glucose
(10 g), MgSO4 (0.12 g), CaCl2 (0.028 g) and thiamine hydrochloride
(0.001 g) in 1 L of M9 salts. Fed-batch fermentation media (850mL)
contained Na2HPO4 (6.78 g), KH2PO4 (3 g), NH4Cl (2 g), NaCl (0.5 g)
and (NH4)2SO4 (1 g). Antibiotics were added where appropriate to the
following final concentrations: chloramphenicol (in methanol),
17mg/L; kanamycin, 50mg/L; ampicillin, 100mg/L. Isopropyl-β-D-
thiogalactopyranoside (IPTG) was prepared as a 100mM stock solu-
tion. Solutions of M9 salts, glucose, MgSO4, and CaCl2 were autoclaved
separately and then mixed. Solutions of antibiotics, IPTG, and thiamine
hydrochloride were filtered through 0.22 µm sterile membrane filters.
Standard protocols were used for the construction, purification, and
analysis of plasmid DNA (Sambrook et al., 2000). Bacterial genomic
DNAs were isolated using the PureLink™ genomic DNA mini kit
(Life Technologies). PCR amplifications were carried out using KOD
HotStart DNA polymerase by following manufacturer's protocol.
Restriction endonucleases were purchased from New England
Biolabs. Electroporation was performed with Electroporator 2510
(Eppendorf AG). Primer synthesis and DNA sequencing services were
provided by Eurofins MWG Operon. Primers used in this study are
listed in Table 1S.
2.2. Analytical methods
Concentrations of accumulated metabolites in culture medium were
quantified by 1H NMR. Samples of fermentation broth were centrifuged to
obtain cell-free broth, which was subsequently mixed with D2O at a 9:1
(v/v) ratio. The sodium salt of 3-(trimethylsilyl)propionic-2,2,3,3-d4 acid
(TSP) was included in the D2O at a known concentration as the internal
standard for calibration and quantification purpose. All 1H NMR spectra
were recorded on a Bruker Avance III-HD NMR Spectrometer (300MHz).
A solvent suppression program was applied to suppress the signal of
water. Concentrations were determined by comparison of integrals
corresponding to each compound with the integral corresponding to
TSP (δ=0.00 ppm). A standard concentration curve was determined for
each metabolite of interest. Compounds were quantified using following
resonance signals: 1,2-PDO (δ 1.12, d, 3H); ethanol (δ 1.20, t, 3H); lactate
(δ 1.35, d, 3H); alanine (δ 1.50, d, 3H); acetate (δ 1.94, s, 3H); pyruvate
(δ 2.38, s, 3H); glucose (δ 3.25, t, 1H (β)). The enantiomeric purity of 1,2-
PDO was analyzed following a previously reported method (Niu and Guo,
2015).
2.3. Enzyme assays
Enzyme assays were conducted using cell-free lysate. Cells were
collected by centrifugation followed by the removal of supernatant.
Harvested cells were lysed using BugBuster® protein extraction reagent
Fig. 1. Biosynthetic pathways of 1,2-PDO. a. Artificial pathway. (a1) lactate dehydrogenase (ldhA or lldh); (a2) lactoyl-CoA transferase (pct); (a3) CoA-dependent aldehyde
dehydrogenase (pduP); (a4) lactaldehyde reductase (yahK). b. Natural pathway. (b1) methylglyoxal synthase; (b2) aldehyde oxidoreductase; (b3) glycerol dehydrogenase; (b4)
methylglyoxal reductase; (b5) 1,2-propanediol reductase.
Table 1
Bacterial strains and plasmids used in the study.
strain/plasmid characteristics source
MG1655 wild-type K12 CGSC 6300a
Δ3 MG1655, ΔadhE, Δdld, ΔlldD 21
Δ7 Δ3, ΔfrdA, ΔpflB, ΔmgsA, ΔaldA this study
Δ8 Δ7, ΔarcA this study
Δ8 lldh Δ8, replaced the ldhA gene with the
lldh gene
this study
Pediococcus acidilactici wild-type DSMZ 20284
2.094 CmR, yahK in pSU18 21b
2.096 ApR, pduP and pct in pJF118EH 21c
a CGSC, Coli Genetic Stock Center, http://cgsc2.biology.yale.edu.
b renamed from pWN2.094; c. renamed from pWN2.096-yahK.
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(EMD Millipore). The cell-free lysate was obtained by centrifugation at
21,300g for 30min at 4 °C. Activities of the lactoyl-CoA transferase,
lactoyl-CoA dehydrogenase, and lactaldehyde reductase were deter-
mined by following previously reported methods (Niu and Guo, 2015).
Lactate dehydrogenase activities were determined by measuring the
pyruvate-dependent oxidation of NADH at 37 °C (Zhou et al., 2003a).
Protein concentrations were determined using the Bio-Rad protein
assay kit (Bio-Rad Laboratories). Biotek Synergy H1 hybrid platereader
was used to record absorbance changes.
2.4. Host strain construction
A previously constructed E. coli strain Δ3 was used as the initial
parent strain in this study (Niu and Guo, 2015). A two-step scarless
chromosomal modification method was carried out using the λ Red-
mediated recombineering method (Zhang et al., 1998; Sharan et al.,
2009) for the sequential deletion of E. coli genes frdA, pflB, mgsA,
aldA, arcA and the replacement of ldhA gene (encodes D-lactate
dehydrogenase) with the Pediococcus acidilactici lldh gene (encodes
L-lactate dehydrogenase). The sacB-encoded Bacillus subtilis levansu-
crase was used as the counterselection marker (Edwards et al., 1998).
The genotypes of all candidate strains were confirmed by DNA
sequencing of the modified sites.
2.5. Batch fermentation
Single colony of an E. coli strain was introduced into 5mL of LB
media containing appropriate antibiotics. The seed culture was culti-
vated at 37 °C for 12 h with shaking. A 0.5mL aliquot of the seed
culture was transferred into 9.5mL of freshly prepared M9 glucose
media with appropriate antibiotics and IPTG (0.25mM) in a 12mL
serum vial. The vial was then flushed with N2, capped with a rubber
stopper and aluminum cap, and sealed using a crimper. The anaerobic
culture was cultivated at 37 °C with shaking for 72 h. To achieve micro-
aerobic cultivation conditions, a 21 G needle was inserted into the
rubber stopper to allow the diffusion of air into the sealed vials. Batch
fermentations were run in triplicate. Results were reported as the
average of the three runs.
2.6. Fed-batch fermentation
Fed-batch fermentations were carried out in a 2-L working volume
BIOSTAT® B bioreactors (Sartorius Stedim Biotech). Temperature and
pH were controlled with proportional-integral-derivative (PID) control
loops. The temperature was maintained at 37 °C. The pH was con-
trolled at 7.0 by the addition of acid (2 N H2SO4) and base solutions
(concentrated NH4OH at the aerobic stage or 20% NaHCO3 at the
micro-aerobic stage). Dissolved oxygen was measured using an
OxyFerm probe. A seed culture was started by the introduction of a
single colony into 5mL of M9 glucose medium. Culture was grown at
37 °C with shaking for 16 h and subsequently transferred into 95mL of
M9 glucose medium. The culture was grown under the same conditions
for an additional 10 h. A fermentation was initiated by transferring the
seed culture (100mL) into the fermentation vessel, which contained
the fed-batch fermentation medium (850mL) and 20 g of glucose (50
mL). The total initial volume of the fermentation culture was 1 L. A
two-stage cultivation scheme was used. The first stage took approxi-
mately 8 h. At the first stage, the D.O. was maintained at 10% air
saturation through sequential ramping of impeller speed and airflow
rate to the preset values. At this point, the OD600 nm reached approxi-
mately 10. Expression of the 1,2-PDO pathway was induced by IPTG at
a final concentration of 0.25mM. Following an additional 1 h of
cultivation, the microaerobic stage was initiated by reducing the airflow
rate to 20 cm3 per minute (ccm). This was defined as t = 0 h in the fed-
batch fermentations. At the same time, 100 g of glucose in solution
(600 g/L) was fed into the fermenter at a constant rate over 24 h.
Throughout the second stage, the D.O. value registered as 0.0% air
saturation. Appropriate antibiotics were included at every culturing
stage. Fed-batch fermentations were run in triplicate. Results were
reported as the average of three runs.
2.7. In silico simulation
The in silico simulation was performed by using the E. coli genome-
scale metabolic model iML1515 (Monk et al., 2017) consisting of 2719
metabolic reactions and 1192 unique metabolites in the COnstraint-
Based Reconstruction and Analysis Toolbox v2.0 (COBRA toolbox)
(Schellenberger et al., 2011). The model was modified to enable the
synthetic pathway of lactic acid to 1,2-PDO conversion. In addition to
the gene-protein-reaction relationship (GPR) for the three reactions
catalyzed by enzymes Pct, PduP, and YahK, a transport reaction for the
export of 1,2-PDO was also included. Constraint-based flux analysis
was performed on strains derived from the rationally engineered host
Δ7, in which genes dld, lldD, adhE, frdA, pflB, mgsA, and aldA were
deleted. To implement the gene deletion during the in silico simulation,
fluxes through the corresponding reactions were set to zero. The Flux
Variability Analysis (FVA) (Mahadevan and Schilling, 2003) was
performed using the built-in function of COBRA toolbox
(Schellenberger et al., 2011).
3. Results
3.1. Construction of E. coli host for the accumulation of D-lactic acid
To enable the de novo biosynthesis of 1,2-PDO from sugar
substrate, we first took a rational approach to design an E. coli host.
Since lactate is the direct precursor of 1,2-PDO biosynthesis in our
previously reported synthetic pathway, we initially targeted the con-
struction of an E. coli host that is capable of homolactate fermentation
based on literature reports (Zhou et al., 2003b; Wang et al., 2012).
Genes encoding enzymes in fermentative production of ethanol (adhE),
succinate (frdA), and formate (pflB) were deleted from the genome of
E. coli K-12 parent MG1655 in order to eliminate competing pathways
that can lead to the accumulation of byproducts. To prevent possible
backflux from lactate to pyruvate, the dld and lldD genes, which encode
two membrane-associated lactate dehydrogenases, were also deleted.
Our previous report showed that an E. coli strain was able to convert
lactate stereoisomers into 1,2-PDO stereoisomers with virtually no loss
of optical purity (Niu and Guo, 2015). To explore the potential of
stereospecific de novo biosynthesis, we also eliminated genes that
contribute to possible stereo-center scrambling. Since the optical purity
of 1,2-PDO directly relies on the optical purity of lactate, the
methylglyoxal bypass, which was identified to be the source of
racemization in lactate fermentation (Grabar et al., 2006), was
inactivated through the deletion of methylglyoxal synthase encoding
gene (mgsA). The aldA gene, which encodes a broad substrate
specificity aldehyde dehydrogenase, was also deleted to lead to strain
Δ7. Removal of the AldA activity benefits the 1,2-PDO biosynthesis
through the minimization of the backflux from lactaldehyde to lactate.
Strain Δ7 was first evaluated for its ability to accumulate D-lactic
acid under anaerobic growth condition in sealed serum vials. Cells were
cultured in M9 minimal medium with glucose as the sole carbon
source. To avoid perturbation to the culturing condition, a single
sample was taken at 72 h. The cell density reached an OD600 nm of 1.5,
while 47.8 ± 1.2mM of lactate was accumulated in a 147.0 ± 3.7%
(mol/mol) yield. Besides lactate, a low concentration of acetate (1.3 ±
0.2mM) was the only other detectable metabolite in 1H NMR analysis.
The yield of lactate synthesized by Δ7 is comparable to previously
reported E. coli strain cultured under similar conditions (Chang et al.,
1999).
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3.2. De novo biosynthesis of R-1,2-PDO via D-lactate
The lactate to 1,2-PDO segment of the synthetic pathway was
installed in strain Δ7 by transforming the host cells with two previously
constructed plasmids, 2.094 and 2.096 (Niu and Guo, 2015). Plasmid
2.094 contains a gene cassette of pduP and pct, which encodes the
lactoyl-CoA dehydrogenase and the CoA transferase, respectively.
Plasmid 2.096 encodes the lactaldehyde reductase (yahK). The tran-
scription of genes on both plasmids was controlled through the lac
operators embedded in the promoter. A plasmid-borne copy of the lacI
gene resides on 2.094 to enable stringent control of the gene expres-
sion. The resulting strain was first examined under anaerobic condi-
tions in serum vials (column 1, Table 2). Following 72 h of cultivation,
1,2-PDO was accumulated at 4.2 ± 0.4mM with a yield of 11.8 ± 1.0%
(mol/mol) from glucose. Other metabolites, including lactate (48.5 ±
0.9mM), acetate (1.5 ± 0.2mM) and ethanol (0.9 ± 0.1mM), were
also observed. The combined yield of 1,2-PDO and lactate was 146.8 ±
4.0%, which is similar to the lactate yield of the host strain Δ7. Deletion
of the adhE eliminated the ethanol production by Δ7 when the host
itself was cultured under the anaerobic condition. Ethanol produced by
strain in Δ7/2.094/2.096 is likely due to the introduction of the
1,2-PDO pathway. In particular, the promiscuous reduction activity
of the PduP enzyme on acetyl-CoA led to the formation of acetaldehyde,
which can be further reduced to form ethanol (Niu and Guo, 2015).
The anaerobic synthesis of lactate through glycolysis from glucose
by E. coli is a pathway with perfect balance between the generation and
the consumption of the reducing equivalents, while the conversion
from lactate to 1,2-PDO constitutes two additional reduction steps. In
addition, the PduP enzyme, which functions at the first reduction step
from lactate to 1,2-PDO (Fig. 1a), has poor kinetics on the nonnative
substrate, lactoyl-CoA (Niu and Guo, 2015). Insufficient supply of
NADH/NADPH can therefore lead to accumulation of lactate and low
titer and yield of 1,2-PDO under the anaerobic condition as observed
above. To this end, we further explored whether changes in culturing
conditions can improve the titer and yield of 1,2-PDO. Since higher
NADH per glucose yield can be achieved through the oxidative branch
of the TCA cycle in the presence of oxygen, strain Δ7/2.094/2.096 was
then examined under microaerobic growth condition in serum vials
(column 2, Table 2). Following 72 h of cultivation, 1,2-PDO was
produced at an elevated titer of 7.0 ± 1.1mM and an improved yield
of 16.9 ± 2.9% (mol/mol). Change of culturing condition also resulted
in acetate at a tenfold higher concentration and more ethanol in the
media. Although increased biomass was observed under the micro-
aerobic conditions, the strain produced more 1,2-PDO per cell
(3.7mM/OD600) than that under the anaerobic conditions
(2.8mM/OD600). Since similar activities of pathway enzymes were
observed regardless of the availability of oxygen (data not shown),
change of cellular metabolism is likely the reason for the improvement.
Meanwhile, despite the increased titer and yield of 1,2-PDO, a roughly
20% reduction in the combined yield of lactate and 1,2-PDO was
observed, which is likely the result of losing pyruvate to cell mass and
respiration.
3.3. Optimization of R-1,2-PDO biosynthesis
Engineered E. coli host Δ7 provides the entry point to de novo
biosynthesis of 1,2-PDO from glucose. However, an engineered homo-
lactate-producing strain cannot satisfy the redox requirement to
achieve the maximum titer and yield of 1,2-PDO biosynthesis under
anaerobic growth. The maximum theoretical yield of 1,2-PDO from
glucose is calculated to be 1.5mol/mol under the non-growth condi-
tion. To identify enabling genetic manipulations, we performed in silico
simulation using the modified E. coli genome-scale model iML1515
(Monk et al., 2017) that included deletions in host strain Δ7 and the
1,2-PDO biosynthetic pathway. By setting the biomass production as
the objective function, Flux Variability Analysis (FVA) shows that flux
through 1,2-PDO biosynthesis varied between arbitrary values of 0–
0.153 (mmol/gCDW/h). Comparison of the flux distributions revealed
a small flux through the pyruvate dehydrogenase into the TCA cycle
that led to the increased yield of 1,2-PDO. In addition, the yield of
lactate was predicted to decrease, while the yields of acetate and CO2
should increase. Since the reactions of pyruvate dehydrogenase and
TCA cycle afford additional redox molecules, in silico simulation
indicated a viable strategy to increase the availability of NAD(P)H for
1,2-PDO biosynthesis.
We next sought to engineer an E. coli host that has a partially active
TCA cycle when grown under microaerobic conditions. This was
achieved by the construction of an E. coli Δ8 strain through the deletion
of arcA gene from the Δ7 strain. The ArcA protein is a global
transcriptional regulator. Together with membrane-associated kinase,
ArcB, ArcA regulates the expression of respiratory and fermentative
pathways (Lynch and Lin, 1996). Under anaerobic condition, ArcA
serves as a repressor protein for the expression of enzymes functioning
in the oxidative branch of the TCA cycle. The strategy of ArcA deletion
to enable microaerobic carbon flux into the TCA cycle has been
successfully implemented in the engineering of 1,4-butanediol-produ-
cing E. coli (Yim et al., 2011). Strain Δ8 was first evaluated for lactate
accumulation in sealed serum bottle under anaerobic conditions. After
72 h, Δ8 behaved similarly as strain Δ7 in biomass production
(OD600 nm = 1.6), accumulation of lactate (47.7 ± 0.3mM, in 146.9
± 1.0% (mol/mol) yield) and acetate (1.9 ± 0.2mM). The major
difference was that Δ8 strain also produced a small amount of succinate
(1.4 ± 0.1mM).
The capability of host Δ8 to support 1,2-PDO biosynthesis was then
evaluated using strain Δ8/2.094/2.096 in serum vials. Under the
anaerobic condition (columns 3, Table 2), this strain accumulated
higher concentration and yield of 1,2-PDO in comparison to Δ7/2.094/
2.096. Reduced lactate and increased acetate accumulations were also
observed. Above behaviors are consistent with the simulation results.
Similar to the observation when host Δ7 was used, the 1,2-PDO titer
Table 2
Cell growth and metabolite accumulation of serum vial experiments.
Δ7 Δ8 Δ8 lldh
anaerobic micro-aerobic anaerobic micro-aerobic anaerobic micro-aerobic
OD600nm 1.5 ± 0.1 1.9 ± 0.1 1.4 ± 0.1 1.9 ± 0.1 0.8 ± 0.1 1.0 ± 0.1
1,2-PDO 4.2 ± 0.4 7.0 ± 1.1 5.5 ± 0.2 10.1 ± 0.7 0.5 ± 0.1 4.0 ± 0.1
lactate 48.5 ± 0.9 42.3 ± 1.0 47.7 ± 0.9 40.5 ± 0.9 11.4 ± 3.3 8.6 ± 3.4
ethanol 0.9 ± 0.1 2.4 ± 0.5 1.4 ± 0.1 3.1 ± 0.7 0.31 ± 0.1 2.8 ± 0.1
acetate 1.5 ± 0.2 15.1 ± 2.2 3.1 ± 0.5 17.3 ± 2.0 0.7 ± 0.1 17.6 ± 1.8
PDO yield 11.8 ± 1.0 16.9 ± 2.9 14.5 ± 1.0 22.3 ± 1.8 4.5 ± 0.2 12.5 ± 0.3
(PDO+lactate) yield 146.8 ± 4.0 118.4 ± 5.4 144.7 ± 3.6 111.6 ± 4.1 105.1 ± 6.8 38.4 ± 6.9
* Each host was transformed with plasmids 2.094 and 2.096. Data was collected 72 h after the inoculation. The metabolite concentrations are in mM. The yields are expressed as % (mol
of metabolite per mol of glucose). The data are the average of three independent trials.
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under the microaerobic condition (column 4, Table 2) was higher than
that under the anaerobic condition (column 3, Table 2). In the
meantime, a lower concentration of lactate was observed for the Δ8
strain when low level of O2 was available, which also led to a reduced
combined yield of PDO and lactate. A small amount of succinate (1.0
± 0.1mM) was only observed under the anaerobic condition (data not
included in Table 2). Above data showed that the ArcA deletion strategy
succeeded in improving the biosynthesis of 1,2-PDO.
3.4. S-1,2-PDO biosynthesis in L-lactate-producing E. coli host
A major benefit of our artificial 1,2-PDO biosynthetic pathway is the
facile production of the R- or S- stereoisomer by switching between the
D- and the L-lactate biosynthetic precursors (Fig. 1a). To enable the de
novo biosynthesis of S-1,2-PDO, E. coli host Δ8 lldh was constructed by
replacing the endogenous ldhA gene with the lldh gene from
Pediococcus acidilactici (Zhou et al., 2003a). Strain Δ8 lldh was first
evaluated for lactate accumulation in serum vials under anaerobic
conditions. An OD600 nm value of 0.8 was reached, which is only around
50% of the cell density achieved by the two engineered D-lactate-
producing hosts, Δ7 and Δ8. Lowered concentrations of lactate (32.0 ±
2.2mM, in 130.0 ± 5.9% (mol/mol) yield) were produced. In addition
to acetate (2.4 ± 0.1mM), the strain accumulated other C3 metabolites
including pyruvate (3.2 ± 0.3mM) and alanine (1.2 ± 0.1mM).
Succinate was not observed in the culture medium. Both pyruvate
and alanine are not common fermentation products of E. coli. Their
accumulations were interpreted as the result of insufficient lactate
dehydrogenase activities. The hypothesis was supported by the ob-
servation of reduced lactate production, albeit of similar combined
yield of C3 compounds (147.9 ± 10.6%, mol/mol) to those of the
D-lactate producing hosts. To test this hypothesis, enzyme assays of
lactate dehydrogenase were performed using cell lysate of E. coli Δ7, Δ8,
and Δ8 lldh that were cultured under the same anaerobic conditions
(Fig. 2). Similar activities (around 0.1 U/mg) were observed in the two
strains (Δ7 and Δ8) that expressed the native D-lactate dehydrogenase.
However, the L-lactate dehydrogenase activity cannot be unambigu-
ously detected in the cell lysate of Δ8 lldh, due to background activities
of other NADH oxidizing enzymes.
1,2-PDO accumulation by strain Δ8 lldh/2.094/2.096 was tested in
serum vials. Under anaerobic condition, the cell growth reached similar
density as when the host strain was cultured. Both lactate (11.4 ± 3.3
mM) and 1,2-PDO (0.5 ± 0.1mM) was accumulated at reduced
concentrations and yields in comparison to those by strain Δ8/2.094/
2.096 (column 5, Table 2). The same trend of reduced cell growth, titer
and yield of lactate and 1,2-PDO was also observed when limited
oxygen was available (column 6, Table 2). The accumulations of both
pyruvate and alanine were observed as well (data not shown).
3.5. De novo biosynthesis of 1,2-PDO stereoisomers under fermenter-
controlled conditions
The biosynthesis of R-1,2-PDO by strains Δ7/2.094/2.096 and Δ8/
2.094/2.096 was further examined and compared under fermenter-
controlled cultivation conditions. To achieve higher titer and yield, a
two-stage cultivation scheme was implemented. At the first stage, the
cells were grown under aerobic condition in order to accumulate cell
mass and shorten the overall process time. The expression of the
plasmid-encoded pathway enzymes was induced 1 h prior to the
transition into the second cultivation stage, during which limited
amount of air (20 ccm) was sparged into the culture vessel with a
stirring rate of 560 rpm. Fermentation was continued under the
microaerobic condition for an additional 24 h while glucose was fed
to the cells at a constant rate. Cell density, metabolite accumulations,
and activities of pathway enzymes (Fig. S1) were analyzed at indicated
time points. The cell growth occurred mainly at the first stage. A similar
growth profile was observed for the two strains (Table S2). A roughly
15% increase in cell density was observed in the first 4 h after the
initiation of the second stage (Fig. 3A and C). For the Δ7-derived strain,
R-1,2-PDO was produced at a relatively consistent rate of around 2.7
mmol/L/h (0.2 g/L/h) to reach the final titer of 65.8mM (5 g/L) and
yield of 12.4% (mol/mol). For the Δ8-derived strain, a higher volu-
metric productivity of R-1,2-PDO at around 5.5mmol/L/h (0.4 g/L/h)
was achieved, which was accompanied by a higher final titer (131.8
mM, 10 g/L) and higher yield (24.9%, mol/mol). Besides R-1,2-PDO,
lactate was the major byproduct accumulated by both strains, although
a higher titer of R-1,2-PDO by Δ8 strain led to a slightly reduced
accumulation of lactate (452mM, 40.8 g/L, 86.0% (mol/mol)) in
comparison to that of Δ7 strain (466mM, 42.0 g/L at 88.5% (mol/
mol)). Another major difference between the two strains was the
drastically reduced acetate accumulation in the absence of ArcA
expression. A 25.7% reduction in acetate production was observed
for strain Δ8/2.094/2.096 (115.2mM) in comparison to strain
Δ7/2.094/2.096 (155mM). Other minor metabolites, including etha-
nol, pyruvate and alanine, were observed at similar concentrations at
every time point for both strains (Fig. 3B and D).
The biosynthesis of S-1,2-PDO by strain Δ8lldh/2.094/2.096 was
examined under the same fermenter-controlled cultivation conditions.
At the aerobic stage, no growth defect was observed (Table S2). The
result indicates that the low biomass production by Δ8 lldh strains
under limited availability of oxygen is likely caused by the inefficient
recycling of redox molecules due to low lactate dehydrogenase activ-
ities. Without this limitation, the S-1,2-PDO-producing construct grew
similarly as its R-1,2-PDO-producing counterpart (Table S2). At the
second microaerobic stage, the two strains also showed very similar
growth and 1,2-PDO production profiles (Fig. 3C and E). The Δ8 lldh
construct reached a volumetric productivity of S-1,2-PDO at 5.1mmol/
L/h (0.37 g/L/h), a final titer of 122.6mM (9.3 g/L) and a yield at
23.2% (mol/mol), which were comparable to the values of the Δ8
construct. However the accumulation profiles of lactate and other
metabolites by the two strains were drastically different (Fig. 3D and
F). Instead of lactate (121.1mM), pyruvate (205.2mM) was accumu-
lated as the major biosynthetic intermediate by the Δ8 lldh strain. The
final concentration of acetate was further reduced by almost twofold,
while concentrations of alanine and ethanol increased.
To further explore the effect of aeration on the biosynthesis of 1,2-
PDO stereoisomers under the fermenter-controlled conditions, strains
Δ8/2.094/2.096 and Δ8lldh/2.094/2.096 were evaluated using the
same cultivation scheme as above but with lowered stirring rate at
280 rpm in the second stage. The two strains showed similar growth
profiles, where the cell density constantly declined at the microaerobic
stage of the cultivation (Fig. 4A and C). In comparison to fermentations
with stirring rate of 560 rpm, lowered aeration led to increased
accumulation of R-1,2-PDO by strain Δ8/2.094/2.096 (227.9mM,
17.3 g/L) at higher yield and productivity (42.2% (mol/mol), 0.72 g/
Fig. 2. The lactate dehydrogenase activities of E. coli hosts. One unit of enzyme activity
is defined as the oxidation of 1 μmol of NADH in one minute at 37 °C. The data is the
average of three measurements. The error bars indicate the standard deviation.
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L/h) (Fig. 4A) and reduced accumulations of lactate (380.7mM, 34.3
g/L, 69.4% (mol/mol)) and other metabolites, including acetate,
pyruvate, and alanine (Fig. 4B). An opposite trend of metabolite
accumulation was observed for strain Δ8lldh/2.094/2.096, which
showed poor glucose uptake at the microaerobic stage of the cultivation
(Fig. S2). As the result, S-1,2-PDO was synthesized at a final concen-
tration of 18.6mM (1.4 g/L, 11.3% (mol/mol)) (Fig. 4C), which
represents an approximate 85% reduction from conditions with higher
stirring rate. Pathway intermediates (pyruvate and lactate) and all
byproducts were also produced at low concentrations (Fig. 4D).
To confirm the stereospecificity of the de novo biosynthesis,
1,2-PDO from fermentations of both the Δ8 and Δ8 lldh constructs
were subjected to optical purity analysis (Fig. 5). Enantiomeric excess
of 97.5% and 99.3% were observed for the R- and the S- isomer,
respectively.
4. Discussion and conclusions
Implementation of designed synthetic pathways to expand the
metabolic and catalytic diversity of platform host strains provides
great opportunities to find straightforward solutions to challenging
metabolic engineering problems. Addition of a limited number of
biochemical reactions to a well-studied metabolic network extends
the product profile of the host. In the meantime, host engineering
benefits from readily available knowledge of cell physiology and genetic
tools. To circumvent a highly cytotoxic biosynthetic intermediate in a
naturally existing 1,2-PDO biosynthetic pathway, we published an
initial study to demonstrate the feasibility of direct conversion of
lactate stereoisomers into corresponding 1,2-PDO isomers (Niu and
Guo, 2015). The current study further established the entire pathway in
E. coli host strains to achieve the de novo and stereospecific biosynth-
esis of 1,2-PDO isomers using glucose as the carbon source. Because
lactic acid fermentation by E. coli strain was well-established, initial
strain engineering was focused on the deletion of competing pathways
Fig. 3. Biosynthesis of R-1,2-PDO and S-1,2-PDO by E. coli strains under fermenter-controlled conditions (560 rpm stirring rate). A. Time courses of cell growth and 1,2-PDO
concentrations of Δ7/2.094/2.096. B. Time courses of metabolite accumulations of Δ7/2.094/2.096. C. Time courses of cell growth and 1,2-PDO concentrations of Δ8/2.094/2.096. D.
Time courses of metabolite accumulations of Δ8/2.094/2.096. E. Time courses of cell growth and 1,2-PDO concentrations of Δ8lldh/2.094/2.096. F. Time courses of metabolite
accumulations of Δ8lldh/2.094/2.096. The data is the average of three fermentation runs. The error bars indicate the standard deviation.
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and the elimination of possible backflux routes, which led to a strain
that produced R-1,2-PDO at 4.2mM under anaerobic and 7.0mM
under microaerobic conditions in serum vials. Although a higher cell
density was reached with increased availability of oxygen, the increased
titer cannot be completely attributed to the increased biomass produc-
tion, due to the increased yield and cell productivity, 3.7 vs. 2.7 (mM
per OD600nm). We argued that increased availability of reducing
equivalents, which is key in engineering a highly efficient 1,2-PDO
producer, played a major role. By applying simulation using in silico
model, we identified the control of the flux into the TCA cycle as a
viable route of overproducing NAD(P)H. Elimination of the regulatory
protein ArcA in above host further improved the yield and titer of
1,2-PDO under both the anaerobic and microaerobic conditions. The
strategy was further confirmed to be effective when the Δ7 and Δ8
derived strains were examined under fermenter-controlled, two-stage
cultivation conditions. The titer, yield and volumetric productivity of R-
1,2-PDO all showed a nearly twofold increase in the deregulated strain.
Additional insights into the synthetic pathway and the engineered
strains were obtained when the behaviors of strain Δ8/2.094/2.096
(producer of R-isomer) and strain Δ8lldh/2.094/2.096 (producer of S-
isomer) were examined under fermenter-controlled cultivation condi-
tions (Table 3). At a stirring rate of 560 rpm, strain Δ8 showed
moderate growth in the first 12 h of cultivation followed by a slow
decline of cell density at the microaerobic stage. At a stirring rate of
280 rpm, continuous decrease of cell density was observed. Since
aeration is the only variable that was changed, the results indicate that
the oxygen transfer rate at low stirring rate is not sufficient to sustain
the initial high cell density resulting from the aerobic stage of the
cultivation. This condition of reduced oxygen availability led to
increased titer and yield of R-1,2-PDO by the Δ8 strain, while the
combined yield of all C3 metabolites stays similar to that of the
condition of higher aeration (Table 3). The observation demonstrates
that to improve the availability of intracellular redox molecules by
controlling the aerobic respiration is still a viable strategy for strains
with deregulated microaerobic metabolism via the arcA deletion.
Systematic optimization of the fermentation process will be explored
to further improve the R-1,2-PDO biosynthesis. Unlike the observation
in serum vials, the Δ8lldh strain did not show different biomass profile
Fig. 4. Biosynthesis of R-1,2-PDO and S-1,2-PDO by E. coli strains under fermenter-controlled conditions (280 rpm stirring rate). A. Time courses of cell growth and 1,2-PDO
concentrations of Δ8/2.094/2.096. B. Time courses of metabolite accumulations of Δ8/2.094/2.096. C. Time courses of cell growth and 1,2-PDO concentrations of Δ8 lldh/2.094/2.096.
D. Time courses of metabolite accumulations of Δ8 lldh/2.094/2.096. The data is the average of three fermentation runs. The error bars indicate the standard deviation.
Fig. 5. Enantiomeric purity analysis of microbial synthesized 1,2-PDO isomers.
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from that of Δ8 strain at the microaerobic stage. The strain also
produced similar titer and yield of 1,2-PDO as the Δ8 strain at the
stirring rate of 560 rpm. Based on the undetectable L-lactate dehy-
drogenase activity (Fig. S1) and our hypothesis that growth of Δ8 lldh
cell was limited by the turnover of redox molecules when oxygen is
limited, the results indicate that cell growth and 1,2-PDO synthesis is
not coupled at the second stage of fermentation under this condition. It
is more likely that the S-1,2-PDO biosynthesis is mainly controlled by
the kinetics of the pathway enzymes. One intriguing result is the altered
ratio between pathway intermediates and the final product. The molar
ratio of pyruvate: lactate:1,2-PDO of Δ8 strain was roughly 0.24:3.4:1
at 24 h, while the value changed to 1.7:0.94:1 for Δ8 lldh strain. The
reduced lactate dehydrogenase activities in the Δ8lldh strain could
benefit the subsequent reduction steps through presumably increased
availability of reducing equivalents. On the other hand, when the
stirring rate was reduced to 280 rpm, the Δ8lldh strain showed
drastically reduced metabolic activity, which led to glucose accumula-
tion and low titers of all metabolites, including the product, S-1,2-PDO.
The different behavior between Δ8 and Δ8lldh strains under the
reduced aeration condition pinpoints the strategy for further optimiza-
tion of S-1,2-PDO biosynthesis is to increase the kinetics of the L-
lactate biosynthesis reaction.
A hypothetical two-step conversion via the intermediacy of lactalde-
hyde was first proposed for the observed reduction of lactate into
1,2-PDO by anaerobic cultures of Lactobacillus buchneri strains
(Elferink et al., 2001). However, the genetic elements of the process
are still unknown. A two-enzyme cascade consisting of a carboxylic acid
reductase (CAR) and a lactaldehyde reductase was recently constructed to
mimic the proposed two-step pathway, albeit with low efficiency due to
poor kinetics of CAR on lactate substrates (Kramer et al., 2018). In this
report, metabolic engineering strategies were successfully devised and
applied to the construction of E. coli hosts for the stereospecific de novo
biosynthesis of 1,2-PDO isomers through the reduction of lactate via a
three-enzymes pathway (Fig. 1a). To the best of our knowledge, these
engineered strains achieved the highest titer of 1,2-PDO stereoisomers
with high optical purity in comparison to published results in peer-
reviewed journals. The current yield of R-1,2-PDO biosynthesis is only
about 28% of the maximum theoretical yield, while S-1,2-PDO biosynth-
esis is only about 16%. In addition to aforementioned approaches, such
as process optimization, we perceive that further improvement lies in
successfully identifying and implementing strategies to further increase
the availability of redox molecules and/or optimizing the kinetics of
pathway enzymes.
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Figure S1.  Specific activity of 1,2-PDO pathway enzymes in fed-batch fermentations.  All 
numbers are reported as units of enzyme activity per mg of soluble cell lysate.  A. Lactate 
dehydrogenase (LdhA).  One unit of LdhA was defined as the oxidation of 1 µmol of NADH per min 
at 37 °C; B. Lactoyl-CoA transferase (Pct).  One unit of Pct was defined as the formation of 1 µmol 
of lactoyl-CoA per min at 37 °C; C. Lactoyl-CoA reductase (PduP).  One unit of PduP was defined 
as the oxidation of 1 µmol of NADH per min at 37 °C; D, Lactaldehyde reductase (YahK).  One unit 
of YahK was defined as the oxidation of 1 µmol of NADPH per min at 37 °C.  In each plot, filled 









































Table S2. Cell growth at the aerobic stage of fermentations. 
timea 
 Δ7/2.094/2.098  Δ8/2.094/2.098  Δ8lldh/2.094/2.098  Δ8/2.094/2.098  Δ8lldh/2.094/2.098 
 560 rpm  560 rpm  560 rpm  280 rpm  280 rpm 
-8 h  0.33±0.01  0.33±0.02  0.34±0.01  0.32±0.03  0.33±0.01 
-2 h  7.1±0.5  6.8±0.7  7.4±0.4  7.1±0.9  7.1±0.4 
-1 h  14.7±0.8  14.3±0.6  14.8±0.7  15.0±0.7  16.2±0.6 
0 h  23.8±0.4  24.0±0.5  24.7±1.0  23.8±0.3  24.5±0.5 
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